Compare NAGE & NMCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NAGE | NMCO |
|---|---|---|
| Founded | 1999 | N/A |
| Country | United States | United States |
| Employees | 117 | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 386.0M | 560.1M |
| IPO Year | N/A | 2019 |
| Metric | NAGE | NMCO |
|---|---|---|
| Price | $4.78 | $10.59 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $16.00 | N/A |
| AVG Volume (30 Days) | ★ 1.2M | 136.4K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $20.75 | N/A |
| Revenue Next Year | $19.96 | N/A |
| P/E Ratio | $21.29 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.73 | $9.69 |
| 52 Week High | $14.66 | $11.20 |
| Indicator | NAGE | NMCO |
|---|---|---|
| Relative Strength Index (RSI) | 36.62 | 42.01 |
| Support Level | $4.73 | $10.44 |
| Resistance Level | $5.32 | $10.74 |
| Average True Range (ATR) | 0.28 | 0.10 |
| MACD | 0.02 | -0.03 |
| Stochastic Oscillator | 7.51 | 25.58 |
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.
Nuveen Municipal Credit Opps Fund is a closed-end fund. The fund's objective is to provide a high level of current income exempt from regular U.S. federal income tax and secondarily, total return. It invests in high yielding, low-to medium-quality municipal securities and uses leverage.